Patient-Centered Outcomes Research Institute (PCORI) multisite project to develop treatment decision aids for racial/ethnic minorities with lupus nephritis

por Yazdany, Jinoos, Dall'Era, Maria, Singh, Jasvinder
Publicado 2014

Identification of clinical and serological factors during induction treatment of lupus nephritis that are associated with renal outcome

por Dall'Era, Maria, Levesque, Victoria, Solomons, Neil, Truman, Matt, Wofsy, David
Publicado 2015

Belimumab or anifrolumab for systemic lupus erythematosus? A risk-benefit assessment

por Kirou, Kyriakos A., Dall`Era, Maria, Aranow, Cynthia, Anders, Hans-Joachim
Publicado 2022

Preliminary population-based incidence and prevalence estimates of systemic lupus erythematosus: the California Lupus Surveillance Project

por Dall'Era, Maria C, Snipes, Kurt, Cisternas, Miriam, Gordon, Caroline, Helmick, Charles G
Publicado 2014

A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial

por Tamirou, Farah, Lauwerys, Bernard R, Dall'Era, Maria, Mackay, Meggan, Rovin, Brad, Cervera, Ricard, Houssiau, Frédéric A
Publicado 2015

Estimates of Responsiveness, Minimally Important Differences, and Patient Acceptable Symptom State in Five Patient‐Reported Outcomes Measurement Information System Short Forms in S...

por Katz, Patricia, Pedro, Sofia, Alemao, Evo, Yazdany, Jinoos, Dall'Era, Maria, Trupin, Laura, Rush, Stephanie, Michaud, Kaleb
Publicado 2019

A glimpse into the future of systemic lupus erythematosus

por Aringer, Martin, Alarcón-Riquelme, Marta E., Clowse, Megan, Pons-Estel, Guillermo J., Vital, Edward M., Dall’Era, Maria
Publicado 2022

Differential regulation of the interferon response in systemic lupus erythematosus distinguishes patients of Asian ancestry

por Rector, Ian, Owen, Katherine A, Bachali, Prathyusha, Hubbard, Erika, Yazdany, Jinoos, Dall'era, Maria, Grammer, Amrie C, Lipsky, Peter E
Publicado 2023

Mortality Among Minority Populations with Systemic Lupus Erythematosus, Including Asian and Hispanic/Latino Persons — California, 2007–2017

por Gianfrancesco, Milena A., Dall’Era, Maria, Murphy, Louise B., Helmick, Charles G., Li, Jing, Rush, Stephanie, Trupin, Laura, Yazdany, Jinoos
Publicado 2021

The Impact of Telemedicine on Rheumatology Care

por Tang, Wei, Inzerillo, Sean, Weiner, Julia, Khalili, Leila, Barasch, Julia, Gartshteyn, Yevgeniya, Dall'Era, Maria, Aranow, Cynthia, Mackay, Meggan, Askanase, Anca
Publicado 2022

Outcome of participants with nephrotic syndrome in combined clinical trials of lupus nephritis

por Gomez Mendez, Liliana Michelle, Cascino, Matthew D, Katsumoto, Tamiko R, Brakeman, Paul, Brunetta, Paul, Jayne, David, Dall’Era, Maria, Rovin, Brad, Garg, Jay
Publicado 2019

Protocol for virtual physical examination in an observational, longitudinal study evaluating virtual outcome measures in SLE

por Askanase, Anca D, Aranow, Cynthia, Kim, Mimi Y, Kamen, Diane L, Arriens, Cristina, Khalili, Leila, Tang, Wei, Barasch, Julia, Dall'Era, Maria, Mackay, Meggan
Publicado 2023

Creatinine Fluctuation in Patients With Lupus Nephritis: Considerations for Clinical Trial Endpoints

por Almaani, Salem, Bhatt, Udayan, Arriens, Cristina, Bonfa, Eloisa, Dall’Era, Maria, Houssiau, Frederic, Kalunian, Kenneth, Mackay, Megan, Sanchez-Guerrero, Jorge, Solomons, Neil, Rovin, Brad H.
Publicado 2020

Non-Full House Membranous Lupus Nephritis Represents a Clinically Distinct Subset

por Ye, Julia, Croom, Nicole, Troxell, Megan L., Kambham, Neeraja, Zuckerman, Jonathan E., Andeen, Nicole, Dall’Era, Maria, Hsu, Raymond, Walavalkar, Vighnesh, Laszik, Zoltan G., Urisman, Anatoly
Publicado 2023

Incidence rates of systemic lupus erythematosus in the USA: estimates from a meta-analysis of the Centers for Disease Control and Prevention national lupus registries

por Izmirly, Peter M, Ferucci, Elizabeth D, Somers, Emily C, Wang, Lu, Lim, S Sam, Drenkard, Cristina, Dall'Era, Maria, McCune, W Joseph, Gordon, Caroline, Helmick, Charles, Parton, Hilary
Publicado 2021

Efficacy and Safety of the Bruton's Tyrosine Kinase Inhibitor Evobrutinib in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double‐Blind, Placebo‐Controlled Dose‐...

por Wallace, Daniel J., Dörner, Thomas, Pisetsky, David S., Sanchez‐Guerrero, Jorge, Patel, Anand C., Parsons‐Rich, Dana, Le Bolay, Claire, Drouin, Elise E., Kao, Amy H., Guehring, Hans, Dall'Era, Maria
Publicado 2022

Dynamics of Methylation of CpG Sites Associated With Systemic Lupus Erythematosus Subtypes in a Longitudinal Cohort

por Lanata, Cristina M., Nititham, Joanne, Taylor, Kimberly E., Solomon, Olivia, Chung, Sharon A., Blazer, Ashira, Trupin, Laura, Katz, Patricia, Dall'Era, Maria, Yazdany, Jinoos, Sirota, Marina, Barcellos, Lisa F., Criswell, Lindsey A.
Publicado 2022

Molecular pathways identified from single nucleotide polymorphisms demonstrate mechanistic differences in systemic lupus erythematosus patients of Asian and European ancestry

por Owen, Katherine A., Bell, Kristy A., Price, Andrew, Bachali, Prathyusha, Ainsworth, Hannah, Marion, Miranda C., Howard, Timothy D., Langefeld, Carl D., Shen, Nan, Yazdany, Jinoos, Dall’era, Maria, Grammer, Amrie C., Lipsky, Peter E.
Publicado 2023

Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria

por van Vollenhoven, Ronald, Askanase, Anca D, Bomback, Andrew S, Bruce, Ian N, Carroll, Angela, Dall'Era, Maria, Daniels, Mark, Levy, Roger A, Schwarting, Andreas, Quasny, Holly A, Urowitz, Murray B, Zhao, Ming-Hui, Furie, Richard
Publicado 2022

Lupus community panel proposals for optimising clinical trials: 2018

por Merrill, Joan T, Manzi, Susan, Aranow, Cynthia, Askenase, Anca, Bruce, Ian, Chakravarty, Eliza, Chong, Ben, Costenbader, Karen, Dall’Era, Maria, Ginzler, Ellen, Hanrahan, Leslie, Kalunian, Ken, Merola, Joseph, Raymond, Sandra, Rovin, Brad, Saxena, Amit, Werth, Victoria P
Publicado 2018